Eastwood Bio-Medical Canada Inc. (TSXV:EBM)
Canada flag Canada · Delayed Price · Currency is CAD
1.000
0.00 (0.00%)
Feb 9, 2026, 11:28 AM EST

TSXV:EBM Cash Flow Statement

Millions CAD. Fiscal year is Nov - Oct.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jul '25 Oct '24 Oct '23 Oct '22 Oct '21 Oct '20
Net Income
-0.41-0.46-0.55-0.15-0.6-0.85
Depreciation & Amortization
0.070.110.110.110.110.11
Other Operating Activities
-0.010.0200-0.01-0.02
Change in Accounts Receivable
0.03-0.030-0.0100.07
Change in Accounts Payable
-0.03-0.030.040.01-0.010.02
Change in Unearned Revenue
-0.01-0.060.0500.02-0
Change in Other Net Operating Assets
0.380.420.330.030.380.13
Operating Cash Flow
0.02-0.02-0.02-0-0.12-0.54
Capital Expenditures
----0-0.01-
Investing Cash Flow
----0-0.01-
Short-Term Debt Issued
-0.040.05---
Long-Term Debt Issued
---0.060.020.04
Total Debt Issued
0.040.040.050.060.020.04
Short-Term Debt Repaid
--0.04-0.05---
Long-Term Debt Repaid
----0.03--
Total Debt Repaid
-0.05-0.04-0.05-0.03--
Net Debt Issued (Repaid)
-0.01-0-00.030.020.04
Financing Cash Flow
-0.01-0-00.030.020.04
Net Cash Flow
0.01-0.02-0.020.02-0.1-0.5
Free Cash Flow
0.02-0.02-0.02-0.01-0.12-0.54
Free Cash Flow Margin
3.54%-2.17%-1.95%-0.56%-12.41%-75.55%
Free Cash Flow Per Share
-----0.00-0.01
Levered Free Cash Flow
0.190.180.180.020.11-0.26
Unlevered Free Cash Flow
0.20.180.190.020.11-0.26
Change in Working Capital
0.370.310.420.030.390.22
Source: S&P Global Market Intelligence. Standard template. Financial Sources.